Literature DB >> 24486687

Efficacy of combination of 0.2% GTN and lignocaine ointments in wound healing and pain relief after Milligan Morgan hemorrhoidectomy--a comparison with lignocaine and 0.2% GTN ointments separately.

Khizar Ishtiaque Khan1, Ahmed Waqas2, Muhammad Akmal3, Shahid Mahmood4, Afaq Iqbal5.   

Abstract

OBJECTIVE: To compare the analgesic efficacy and rate of wound healing of combination of 0.2% Glyceryl Trinitrate and 2% lignocaine ointments with 0.2% Glyceryl Trinitrate and 2% lignocaine ointment separately after Milligan Morgan hemorrhoidectomy.
DESIGN: Randomized control trial. PLACE AND DURATION OF STUDY: Combined Military Hospital, Kharian, Malir and Bannu. November 2007 to August 2011. PATIENTS AND METHODS: Patients undergoing Milligan Morgan hemorrhoidectomy were randomized into 3 groups by using computer generated table. Group A received combination of 0.2% Glyceryl Trinitrate and 2% lignocaine ointment, Group B 2% lignocaine and Group C received 0.2% Glyceryl Trinitrate ointment. These ointments were given on twice daily basis. Pain scores were measured on a 100 mm Visual Analog Scale. Pain scores and quantity of oral analgesics used were compared daily until the 7th post-operative day. The time required for complete healing (in weeks) was also compared.
RESULTS: Out of 210 patients, 192 (67 Group A, 64 Group B and 61 Group C) completed the study. Demographic data were comparable in all three groups. There were statistically significant reductions in pain scores and quantity of analgesics used from the first to the fourth post-operative days in Group A. The time required for complete healing was also significantly reduced in the combination group. There were no significant side effects in any group.
CONCLUSION: The combination of 0.2% GTN and 2% lignocaine showed better pain relief resulting in less use of oral analgesics and faster healing of the wound after Milligan Morgan hemorrhoidectomy.
Copyright © 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  GTN; Lignocaine; Milligan Morgan hemorrhoidectomy

Mesh:

Substances:

Year:  2014        PMID: 24486687     DOI: 10.1016/j.ijsu.2014.01.013

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  6 in total

Review 1.  Evidence-Based Management of Pain After Excisional Haemorrhoidectomy Surgery: A PROSPECT Review Update.

Authors:  Tarik Sammour; Ahmed W H Barazanchi; Andrew G Hill
Journal:  World J Surg       Date:  2017-02       Impact factor: 3.352

2.  Effect of Glyceryl Trinitrate Ointment on Pain Control After Hemorrhoidectomy: A Meta-analysis of Randomized Controlled Trials.

Authors:  Jen-Wei Liu; Chao-Chun Lin; Kee-Thai Kiu; Chun-Yu Wang; Ka-Wai Tam
Journal:  World J Surg       Date:  2016-01       Impact factor: 3.352

3.  Topical analgesia following excisional haemorrhoidectomy: a systematic review and meta-analysis of randomised controlled trials.

Authors:  Weisi Xia; Brittany Park; Bacil F Otutaha; Wiremu S MacFater; Andrew D MacCormick; Tarik Sammour; Andrew G Hill
Journal:  Int J Colorectal Dis       Date:  2020-01-02       Impact factor: 2.571

4.  Polyherbal formulation Anoac‑H suppresses the expression of RANTES and VEGF for the management of bleeding hemorrhoids and fistula.

Authors:  Ashwin Porwal; Gopal C Kundu; Gajanan Bhagwat; Ramesh Butti
Journal:  Mol Med Rep       Date:  2021-08-20       Impact factor: 2.952

5.  The Role of Acupuncture in Relieving Post-Hemorrhoidectomy Pain: A Systematic Review of Randomized Controlled Trials.

Authors:  Huan Chen; Weina Zhang; Yuanjie Sun; Ruimin Jiao; Zhishun Liu
Journal:  Front Surg       Date:  2022-03-28

6.  Efficacy of Mesoglycan in Pain Control after Excisional Hemorrhoidectomy: A Pilot Comparative Prospective Multicenter Study.

Authors:  Gaetano Gallo; Massimiliano Mistrangelo; Roberto Passera; Valentina Testa; Mauro Pozzo; Roberto Perinotti; Ivan Lanati; Ivano Lazzari; Paolo Tonello; Elettra Ugliono; Emilia De Luca; Alberto Realis Luc; Giuseppe Clerico; Mario Trompetto
Journal:  Gastroenterol Res Pract       Date:  2018-03-19       Impact factor: 2.260

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.